Research

Energy balance

Disparities in the use of SGLT-2 inhibitors and GLP-1 receptor agonists exist based on race, sex, and socioeconomic status.

Efforts should be made to address these disparities in prescribing practices.

StrongSupportsmedium confidence
However, the use of these agents remains limited by disparities in certain racial/ethnic, sex, and socioeconomic groups.
Apurva Khedagi et al. · American Journal of Preventive Cardiology · 2023

Why this rating

The claim is based on observed disparities mentioned in the abstract.

Source

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

Apurva Khedagi et al. · American Journal of Preventive Cardiology · 2023

DOI 10.1016/j.ajpc.2023.100477

reviewCited 24×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →